Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
B. P. Repsold, S. F. Malan, J. Joubert & D. W. Oliver. (2018) Multi-targeted directed ligands for Alzheimer’s disease: design of novel lead coumarin conjugates. SAR and QSAR in Environmental Research 29:3, pages 231-255.
Read now
Read now
Articles from other publishers (10)
P. Catherene Tomy & C. Gopi Mohan. (2023) Chemical space navigation by machine learning models for discovering selective MAO-B enzyme inhibitors for Parkinson’s disease. Artificial Intelligence Chemistry 1:2, pages 100012.
Crossref
Crossref
Toni Kühl, Maya G. Georgieva, Harald Hübner, Maria Lazarova, Matthias Vogel, Bodo Haas, Martina I. Peeva, Aneliya A. Balacheva, Ivan P. Bogdanov, Luigi Milella, Maria Ponticelli, Tsvetomir Garev, Immacolata Faraone, Roumyana Detcheva, Borislav Minchev, Polina Petkova-Kirova, Lyubka Tancheva, Reni Kalfin, Atanas G. Atanasov, Liudmil Antonov, Tamara I. Pajpanova, Kiril Kirilov, Marcus Gastreich, Peter Gmeiner, Diana Imhof & Nikolay T. Tzvetkov. (2023) Neurotensin(8–13) analogs as dual NTS1 and NTS2 receptor ligands with enhanced effects on a mouse model of Parkinson's disease. European Journal of Medicinal Chemistry 254, pages 115386.
Crossref
Crossref
Merzaka Mettai, Ismail Daoud, Fouzia Mesli, Samir Kenouche, Nadjib Melkemi, Rania Kherachi & Ahlem Belkadi. (2023) Molecular docking/dynamics simulations, MEP analysis, bioisosteric replacement and ADME/T prediction for identification of dual targets inhibitors of Parkinson’s disease with novel scaffold. In Silico Pharmacology 11:1.
Crossref
Crossref
Julia A. Efimova, Anton A. Shetnev, Sergey V. Baykov, Anél Petzer & Jacobus P. Petzer. (2023) 3-(3,4-Dichlorophenyl)-5-(1H-indol-5-yl)-1,2,4-oxadiazole. Molbank 2023:1, pages M1552.
Crossref
Crossref
Xuefei Li, Yanbo Yu & Zhude Tu. (2021) Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer’s Disease and Parkinson’s Disease Treatment (2011–2020). Molecules 26:5, pages 1202.
Crossref
Crossref
Nikolay T. Tzvetkov, Hans-Georg Stammler, Maya G. Georgieva, Daniela Russo, Immacolata Faraone, Aneliya A. Balacheva, Silvia Hristova, Atanas G. Atanasov, Luigi Milella, Liudmil Antonov & Marcus Gastreich. (2019) Carboxamides vs. methanimines: Crystal structures, binding interactions, photophysical studies, and biological evaluation of (indazole-5-yl)methanimines as monoamine oxidase B and acetylcholinesterase inhibitors. European Journal of Medicinal Chemistry 179, pages 404-422.
Crossref
Crossref
Rati Kailash Prasad Tripathi & Senthil Raja Ayyannan. (2019) Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update. Medicinal Research Reviews 39:5, pages 1603-1706.
Crossref
Crossref
Masha G. Savelieff, Geewoo Nam, Juhye Kang, Hyuck Jin Lee, Misun Lee & Mi Hee Lim. (2018) Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade. Chemical Reviews 119:2, pages 1221-1322.
Crossref
Crossref
Nikolay T. Tzvetkov, Hans-Georg Stammler, Silvia Hristova, Atanas G. Atanasov & Liudmil Antonov. (2019) (Pyrrolo-pyridin-5-yl)benzamides: BBB permeable monoamine oxidase B inhibitors with neuroprotective effect on cortical neurons. European Journal of Medicinal Chemistry 162, pages 793-809.
Crossref
Crossref
Devesh Tewari, Adrian M. Stankiewicz, Andrei Mocan, Archana N. Sah, Nikolay T. Tzvetkov, Lukasz Huminiecki, Jarosław O. Horbańczuk & Atanas G. Atanasov. (2018) Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs. Frontiers in Aging Neuroscience 10.
Crossref
Crossref